Phase I/II study of PIXY321 in combination with cyclophosphamide and carboplatin in the treatment of ovarian cancer Conference

Runowicz, CD, Mandeli, J, Speyer, JL et al. (1996). Phase I/II study of PIXY321 in combination with cyclophosphamide and carboplatin in the treatment of ovarian cancer . AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 174(4), 1151-1159. 10.1016/S0002-9378(96)70657-9

Industry Collaboration

cited authors

  • Runowicz, CD; Mandeli, J; Speyer, JL; Wadler, S; Hochster, H; Garrison, L; Holland, JF

sustainable development goals

authors

date/time interval

  • September 7, 1995 -

publication date

  • April 1, 1996

webpage

published in

keywords

  • CHEMOTHERAPY
  • COLONY-STIMULATING FACTOR
  • INTERLEUKIN-3 FUSION PROTEIN
  • Life Sciences & Biomedicine
  • Obstetrics & Gynecology
  • PIXY321
  • Science & Technology
  • antineoplastic agents
  • colony-stimulating factors
  • ovarian carcinoma
  • recombinant fusion proteins

Location

  • NAPA, CA

Digital Object Identifier (DOI)

Conference

  • 14th Annual Meeting of the American-Gynecological-and-Obstetrical-Society

publisher

  • MOSBY-ELSEVIER

start page

  • 1151

end page

  • 1159

volume

  • 174

issue

  • 4